MarketWatch
Search documents
Why stocks are trading on a knife's edge ahead of the Fed's December rate decision
MarketWatch· 2025-11-25 12:15
Core Insights - November has historically been a favorable month for stocks, particularly for the S&P 500, based on its performance over the last 25 years [1] Group 1 - The current year has presented significant challenges, contrasting with the typical positive trend observed in November [1]
Thanksgiving gas prices could be the lowest in years — if you adjust for inflation. Why households are still on edge.
MarketWatch· 2025-11-25 12:00
Core Insights - American consumers are increasingly concerned about rising food prices, indicating a shift in spending priorities and potential impact on consumer behavior [1] Group 1: Consumer Concerns - The rising cost of food is a significant worry for American consumers, overshadowing concerns about gasoline prices [1] - This shift in focus may affect consumer spending patterns, as households prioritize essential goods [1] Group 2: Gasoline Prices - The cost of gasoline is becoming less of a concern for consumers compared to food prices, suggesting a relative stabilization or decrease in gasoline costs [1]
Fund manager who ‘pounded the table' to own Nvidia in 2017 now likes these AI stocks
MarketWatch· 2025-11-25 11:57
Core Insights - Tony Wang identifies promising technology companies, highlighting his ability to recognize potential winners in the tech sector [1] Company Highlights - Nvidia is mentioned as a significant success story, showcasing the potential for growth in the tech industry [1] - Other companies that excite Tony Wang are not specified, indicating a focus on emerging tech opportunities [1]
The case that won't go away: ECB reportedly investigates allegations of financial irregularities at Deutsche Bank
MarketWatch· 2025-11-25 11:31
The former employee suing Deutsche Bank for €152 million has alleged the bank misused "netting†practices to boost its balance sheet. ...
They bet everything on Palantir and became millionaires. Inside the market's ultimate cult stock.
MarketWatch· 2025-11-25 11:00
Core Viewpoint - Speculators are actively promoting Palantir Technologies by purchasing corporate merchandise and sharing their enthusiasm on platforms like Reddit, indicating a growing interest and potential investment in the company [1] Group 1: Company Activities - Palantir's supporters are engaging in unique promotional activities, such as buying branded merchandise and showcasing it online to attract attention [1] - The company's CEO, Alex Karp, is being pitched to potential investors, including family members of speculators, highlighting a grassroots effort to build interest in Palantir [1] Group 2: Market Sentiment - The enthusiasm surrounding Palantir reflects a broader trend of retail investors seeking to capitalize on perceived undervaluation and potential growth in the tech sector [1] - The speculative nature of these activities suggests a volatile market sentiment, where investors are willing to take risks based on social media influence and community engagement [1]
Nvidia says it's not Enron. Michael Burry makes a different dot-com parallel.
MarketWatch· 2025-11-25 10:04
Nvidia and Michael Burry, the famed investor who was chronicled in The Big Short by spotting the subprime bubble, appear to be in a war of words. ...
Alphabet's stock rises as possible Meta chip deal highlights new twist in the AI trade
MarketWatch· 2025-11-25 03:23
Core Insights - Meta is reportedly considering the use of Alphabet's custom chips for its data centers, indicating a potential shift in its hardware strategy [1] - The news has led to a decline in shares of Nvidia and AMD, suggesting increased competition in the semiconductor market [1] Company Implications - If Meta adopts Alphabet's custom chips, it could enhance its data center efficiency and reduce reliance on traditional chip suppliers [1] - The move may signal a broader trend of tech companies developing in-house solutions to optimize performance and cost [1] Industry Impact - The potential partnership between Meta and Alphabet could intensify competition among major chip manufacturers, particularly Nvidia and AMD, who may face pressure on market share and pricing [1] - This development highlights the ongoing evolution in the semiconductor industry, where companies are increasingly looking for tailored solutions to meet specific operational needs [1]
This booming tech stock will join the S&P 500 — and it's not Strategy
MarketWatch· 2025-11-24 23:07
Core Insights - A place in the S&P 500 is highly sought after by companies as it significantly broadens their investor base [1] Group 1 - The S&P 500 inclusion enhances a company's visibility and attractiveness to a wider range of investors [1]
Nasdaq has best day since May as Alphabet drives AI rebound. Here's what it means for the rest of Thanksgiving week.
MarketWatch· 2025-11-24 22:44
Core Viewpoint - U.S. stocks experienced a significant rebound, with the Nasdaq Composite index achieving its best performance since May after nearly entering correction territory the previous week [1] Group 1 - The Nasdaq Composite index had its best session since May [1] - The index was close to slipping into correction territory last week [1]
There's still hope GLP-1 drugs could slow the second-biggest type of dementia
MarketWatch· 2025-11-24 21:57
Core Viewpoint - The article discusses the potential of GLP-1 receptor agonists in treating vascular dementia, highlighting a recent study that did not yield positive results, yet some researchers remain optimistic about future possibilities [1] Group 1: Study Results - A recent study investigating the efficacy of GLP-1s in treating vascular dementia failed to show significant benefits [1] - Despite the negative outcome, some researchers believe that further exploration into GLP-1s could still be worthwhile [1] Group 2: Research Perspectives - Some experts are holding out hope that GLP-1s may have therapeutic potential for vascular dementia, suggesting that the initial study may not be the final word on the subject [1] - The ongoing interest in GLP-1s reflects a broader trend in exploring new treatments for neurodegenerative diseases [1]